Detalhe da pesquisa
1.
Evaluation of COVID-19 vaccine effectiveness in different high-risk facility types during a period of Delta variant dominance in the Republic of Korea: a cross-sectional study.
Osong Public Health Res Perspect
; 14(5): 418-426, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37920897
2.
mRNA vaccine effectiveness against SARS-CoV-2 B.1.617.2 (Delta) and B.1.1.529 (Omicron) variant transmission from home care cases to household contacts in South Korea.
Osong Public Health Res Perspect
; 13(6): 435-442, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36617549